Nature of Disclosure: Corrigendum to the Notice of Extra-Ordinary General Meeting (EGM) originally dated 04th June 2026 and emailed to shareholders on 09th June 2026. The EGM is scheduled for Wednesday, 01st July 2026 at 3:30 PM IST to be held through Video Conferencing/Other Audio-Visual Means.

Regulatory Reference: This corrigendum is issued pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Reason for Corrigendum: The Company applied to BSE Limited for in-principle approval for the issuance of 12,00,000 equity shares on a preferential basis. During BSE's review, two proposed allottees were found to have violated Regulation 159(1)(c) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 (ICDR Regulations).

Key Modifications:

1. Disqualification and Removal of Allottees:

  • Sakshi Malani (Sr. No. 1 in the original resolution) sold 75 shares between 18-Feb-2026 and 25-Feb-2026. This sale occurred within 90 trading days preceding the relevant date, violating SEBI ICDR regulations. Consequently, she is disqualified and will not be allotted the proposed 1,50,000 equity shares.
  • Pallapothu Sivakrishna (Sr. No. 18 in the original resolution) sold 77 shares between 23-Feb-2026 and 24-Feb-2026. This sale also violated the same regulation, leading to his disqualification and the cancellation of his proposed allotment of 25,000 equity shares.

2. Reallocation of Shares:

  • The 150,000 shares originally intended for Sakshi Malani have been reallocated to three existing proposed allottees: Suman Rajiv Bihani (Sr. No. 5), Vedant Rajiv Bihani (Sr. No. 6), and Prakash Galda (Sr. No. 7), with each receiving an additional 50,000 shares.
  • The 25,000 shares originally intended for Pallapothu Sivakrishna have been reallocated to the existing proposed allottee T Praveen Kumar (Sr. No. 11).

3. Name Correction:

  • The name of Allottee No. 7 is corrected from 'PRAKASH GADLA' to 'PRAKASH GALDA' due to a typographical error. All references in the resolution and explanatory statement are updated accordingly.

Updated Allotment Details: The total number of shares to be issued remains 12,00,000. The revised list of 16 allottees and their respective allotments is as follows:

  • PEDDI SRIDHAR: 100,000 shares (Non-Promoter)
  • PALAKURTHI RAKESH: 100,000 shares (Non-Promoter)
  • RAHUL INNANI: 100,000 shares (Non-Promoter)
  • SUMAN RAJIV BIHANI: 100,000 shares (Non-Promoter)
  • VEDANT RAJIV BIHANI: 100,000 shares (Non-Promoter)
  • PRAKASH GALDA: 100,000 shares (Non-Promoter)
  • K VARSHA: 50,000 shares (Non-Promoter)
  • VIJAYA SURESH NIMBALE: 25,000 shares (Non-Promoter)
  • PRASANTH SOWMITHRY BRUNDAVANAM: 25,000 shares (Non-Promoter)
  • T PRAVEEN KUMAR: 140,000 shares (Non-Promoter)
  • ALLADI PRAVEEN: 50,000 shares (Non-Promoter)
  • GANGADHAR KATHURI: 10,000 shares (Non-Promoter)
  • RAJENDER BELIDE: 100,000 shares (Non-Promoter)
  • BELIDE VIJAYALAKSHMI: 100,000 shares (Non-Promoter)
  • VENKATRAMANA MANUSANI: 50,000 shares (Non-Promoter)
  • MANUSANI JALAJA LAXMI: 50,000 shares (Non-Promoter)

Financial and Shareholding Impact: The explanatory statement includes updated tables showing the post-allotment shareholding percentages for each allottee. The calculations are based on the existing share capital and account for the full conversion of 33,75,000 outstanding warrants allotted on 10th January 2025. All allottees are classified as Non-Promoters both currently and post-issuance. The corrigendum forms an integral part of the original EGM notice and is available on the company's website (www.novelixpharma.com) and the BSE website.